R. McAlevey Michael's most recent trade in HCA Healthcare Inc was a trade of 2,117 Common Stock done . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HCA Healthcare | Michael R. McAlevey | EVP & Chief Legal & Admin Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 2,117 | 3,227 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Michael R. McAlevey | EVP & Chief Legal & Admin Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 531 | 2,696 (0%) | 0% | 321.9 | 170,940 | Common Stock |
| HCA Healthcare | Michael R. McAlevey | EVP & Chief Legal & Admin Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 11,171 | 11,171 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael R. McAlevey | EVP - Chief Legal & Admin Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 2,274 | 2,274 | - | - | Stock Appreciation Right | |
| HCA Healthcare | R. McAlevey Michael | SVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 11,005 | 11,005 | - | - | Stock Appreciation Right | |
| HCA Healthcare | R. McAlevey Michael | SVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2024 | 1,940 | 4,501 (0%) | 0% | - | Common Stock | |
| HCA Healthcare | McAlevey R. Michael | SVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2024 | 1,940 | 0 | - | - | Restricted Stock Units | |
| HCA Healthcare | McAlevey R. Michael | SVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 283.43 per share. | 28 Jan 2024 | 489 | 4,012 (0%) | 0% | 283.4 | 138,597 | Common Stock |
| HCA Healthcare | Michael R. McAlevey | SVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 12,630 | 12,630 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael R. McAlevey | SVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2023 | 1,940 | 1,940 | - | - | Restricted Stock Units | |
| HCA Healthcare | Michael R. McAlevey | SVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2023 | 1,940 | 3,050 (0%) | 0% | - | Common Stock | |
| HCA Healthcare | Michael R. McAlevey | SVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.77 per share. | 28 Jan 2023 | 489 | 2,561 (0%) | 0% | 254.8 | 124,583 | Common Stock |
| HCA Healthcare | Michael R. McAlevey | SVP & Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 218.56 per share. | 29 Apr 2022 | 1,110 | 1,110 (0%) | 0% | 218.6 | 242,602 | Common Stock |
| HCA Healthcare | Michael R. McAlevey | SVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 13,860 | 13,860 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael R. McAlevey | SVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 13,170 | 13,170 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael R. McAlevey | SVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 3,880 | 3,880 | - | - | Restricted Stock Units |